Deal of The Day! Hurry Up, Grab the Special Discount - Save 25% - Ends In 00:00:00 Coupon code: SAVE25
Welcome to Pass4Success

- Free Preparation Discussions
Mail Us support@pass4success.com
Location US
Mob_nav_barsMENU

PMI PfMP Exam - Topic 8 Question 44 Discussion

Assume you are a functional manager in your medical device company in research and development. Your scientists have determined a new product that will be a breakthrough for the company, and you want to serve as the sponsor for this component and present it to your Portfolio Review Board. You will need resources from other parts of the company to commercialize it. As you prepare your proposal you are following the key descriptors set up by the portfolio staff and will include:
D) Qualitative benefits
A) Risk reduction
B) Regulatory and compliance issues
C) Internal and external dependencies

PMI PfMP Exam - Topic 8 Question 44 Discussion

Actual exam question for PMI's PfMP exam
Question #: 44
Topic #: 8
[All PfMP Questions]

Assume you are a functional manager in your medical device company in research and development. Your scientists have determined a new product that will be a breakthrough for the company, and you want to serve as the sponsor for this component and present it to your Portfolio Review Board. You will need resources from other parts of the company to commercialize it. As you prepare your proposal you are following the key descriptors set up by the portfolio staff and will include:

Show Suggested Answer Hide Answer
Suggested Answer: D

by Valentin at Sep 22, 2022, 12:43 PM

Limited Time Offer

25%

Off

Get Premium PfMP Questions as Interactive Web-Based Practice Test or PDF

Contribute your Thoughts:

0/2000 characters
Submit Cancel
Charlette
9 months ago
Surprised that internal dependencies weren't mentioned earlier!
upvoted 0 times
...
Junita
9 months ago
Really? I’m not sure if qualitative benefits matter that much.
upvoted 0 times
...
Sarina
9 months ago
I think risk reduction is the most critical part here.
upvoted 0 times
...
Virgie
9 months ago
Totally agree, compliance is key for success.
upvoted 0 times
...
Lonny
9 months ago
Don't forget about the regulatory hurdles!
upvoted 0 times
...
Jamika
10 months ago
Qualitative benefits seem a bit vague to me. I hope we can tie them back to tangible outcomes to make a stronger case.
upvoted 0 times
...
Wade
10 months ago
I feel like internal and external dependencies are crucial, but I’m a bit confused about how to present them effectively in the proposal.
upvoted 0 times
...
Annett
10 months ago
I think we had a practice question that focused on regulatory issues, and I recall that they can really impact timelines. We should definitely highlight that.
upvoted 0 times
...
Catarina
10 months ago
I remember we discussed the importance of risk reduction in our last study group, but I'm not entirely sure how to quantify it for the proposal.
upvoted 0 times
...
Adelina
10 months ago
I think I've got a handle on this. The key is to identify the overhead that's not specific to ODUk. I'm going to go with D - APs/PCc.
upvoted 0 times
...
Chana
10 months ago
Okay, I think I've got this. The provider packets in Draft Rosen use the system IP address of the originating PE router as the source IP. That makes sense since the PE is the one doing the encapsulation. I'm confident I can answer this correctly.
upvoted 0 times
...
Odette
10 months ago
Okay, I've got this. The correct answer is option D - you need to configure the domain, numeric ID base, and numeric ID quantity when adding a Cisco Meeting Server to TMS. I'm confident that's the right approach.
upvoted 0 times
...

Save Cancel